Multivessel approach in ST‐elevation myocardial infarction: Impact on in‐hospital morbidity and mortality

Lekston, 2011, Impact of multivessel coronary disease on one‐year clinical outcomes and five‐year mortality in patients with ST‐elevation myocardial infarction undergoing percutaneous coronary intervention, Kardiol Pol, 69, 336 Dziewierz, 2010, Impact of multivessel coronary artery disease and noninfarct‐related artery revascularization on outcome of patients with ST‐elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry), Am J Cardiol, 106, 342, 10.1016/j.amjcard.2010.03.029 Steg, 2012, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation. The Task Force on the management of ST‐elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 Bengalore, 2011, Meta‐analysis of multivessel coronary artery revascularization versus culprit‐only revascularization in patients with ST‐segment elevation myocardial infarction and multivessel disease, Am J Cardiol, 107, 1300, 10.1016/j.amjcard.2010.12.039 Jeger, 2011, Primary PCI in STEMI—dilemmas and controversies: multivessel disease in STEMI patients. Complete versus Culprit Vessel revascularization in acute ST‐elevation myocardial infarction, Minerva Cardioangiol, 59, 225 Vlaar, 2011, Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST‐segment elevation myocardial infarction: a pairwise and network meta‐analysis, J Am Coll Cardiol, 58, 692, 10.1016/j.jacc.2011.03.046 Hannan, 2010, Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST‐segment elevation myocardial infarction patients with multivessel disease, JACC Cardiovasc Interv, 3, 22, 10.1016/j.jcin.2009.10.017 Jo, 2011, Culprit‐lesion‐only versus multivessel revascularization using drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: a Korean acute myocardial infarction registry‐based analysis, Korean Circ J, 41, 718, 10.4070/kcj.2011.41.12.718 Kornowski, 2011, Prognostic impact of staged versus «one‐time» multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS‐AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial, J Am Coll Cardiol, 58, 704, 10.1016/j.jacc.2011.02.071 de Luca, 2009, Risk profile and benefits from Gp IIb‐IIIa inhibitors among patients with ST‐segment elevation myocardial infarction treated with primary angioplasty: a meta‐regression analysis of randomized trials, Eur Heart J, 2705, 10.1093/eurheartj/ehp118 De Luca, 2012, Drug‐eluting vs bare‐metal stents in primary angioplasty: a pooled patient‐level meta‐analysis of randomized trials, Arch Intern Med, 172, 611, 10.1001/archinternmed.2012.758 Carlsson, 2009, Outcome of drug‐eluting versus bare‐metal stenting used according to on‐ and off‐label criteria free, J Am Coll Cardiol, 53, 1389, 10.1016/j.jacc.2008.09.067 Mauri, 2008, Drug‐eluting or bare‐metal stents for acute myocardial infarction, N Engl J Med, 359, 1330, 10.1056/NEJMoa0801485 Yeh, 2011, Predicting the restenosis benefit of drug‐eluting versus bare metal stents in percutaneous coronary intervention, Circulation, 124, 1557, 10.1161/CIRCULATIONAHA.111.045229 Khattab, 2008, Multi‐vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single‐center experience, Clin Res Cardiol, 97, 32, 10.1007/s00392-007-0570-4